Alternatives to Ark Health

NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.

Marked down on: Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)

$1,349/mo (brand-name) sema · $1,069/mo (brand-name) tirz

Brand-name only telehealth provider offering Wegovy, Ozempic, and Mounjaro at standard pharmacy pricing with physician oversight.

Marked down on: Higher brand-name pricing only

$1,350/mo (brand-name) sema · $1,350/mo (brand-name) tirz

A women's desk that pairs a genuine brand-name Ozempic path with low compounded pricing in all 50 states — every rate of which is a yearly subscription.

Marked down on: No month-to-month price is published anywhere — the $179/mo hero now reads “$179/mo all doses, no hidden fees” and the term has moved into a shared footnote under the treatment cards (“Price calculated based on a yearly subscription plan”), the $149/mo microdose tier carries the same term, and the FAQ quotes a third figure at “starting at just $199 per month (with a 3-month plan)”

$1,299/mo (brand-name) sema · $179/mo (see conditions) tirz

Eli Lilly's manufacturer direct-pay channel for Foundayo (orforglipron), the first oral GLP-1 pill for weight loss.

Marked down on: Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI

A heavyweight platform with brand-name access, held back by compounded pricing it does not publish clearly.

Marked down on: Compounded pricing not disclosed up front